Why Tilray and other cannabis stocks just had their best week of 2026
Tilray Brands, Canopy Growth, and Curaleaf Holdings stocks are surging after the FDA says it won’t enforce some regulations for CBD products.
Fight over mandatory cannabis testing picks up steam as bill heads to floor
Maine remains the only state in the country where medical marijuana is not required to be tested for purity or contaminants. Efforts to remedy that have tried and failed in past years.
Are DC breweries allowed to make cannabis drinks? What Bowser wants
A bill proposed by Washington DC Mayor Muriel Bowser would let breweries make cannabis beverages in partnership with medical marijuana producers.
Massachusetts Marijuana Businesses File Lawsuit To Keep Legalization Rollback Measure Off Ballot
Massachusetts marijuana businesses have filed a lawsuit aiming to block an initiative to roll back the state’s voter-approved legalization law from reaching the November ballot. The proposal to repeal …
The Rise of Minor Cannabinoids: How CBN and THCv Are Becoming Cannabis’s Next Big Trend
Taken together, market forecasts, consumer surveys and retail sales data analytics all point to a cannabis industry that is evolving beyond its early focus: THC potency. Minor cannabinoids, such as …
CBD Stocks Creating Opportunities – Established (BCCI), (STG), (WEED), (ACRGF), (RLTR), (CBMJ), and Newcomer (VAPR) Lead the Charge
You would have to be living in isolation to have not picked up on the hottest marijuana derivative consumable and therapeutic center isolate CBD. CBD “Cannabidiol” is the non-psychoactive full spectrum derivative of the hemp and marijuana plant largely credited for the majority of the medical beneficial attributes associated with marijuana.
Finally. Marijuana Gets Reclassified, but Are Pot Stocks Still Too Risky?
Markets don’t usually wait for permission — they anticipate it. That’s why cannabis stocks jumped ahead of the official news that the Justice Dept. would reclassify marijuana from Schedule I to …
How does marijuana rescheduling affect cannabis companies now?
Some operators are seeking partnerships for clinical studies, while others are developing strategies to scale their operations.
Cannabis MSOs to see increased investment, lower taxes from reclassification
Marijuana’s Schedule III shift could boost cannabis MSOs via new capital access and Section 280E tax relief. Read more here.
US reduces marijuana restrictions in lift to ailing industry
The US Justice Department reclassified state-regulated marijuana as a less dangerous drug, a major shift that could increase legal cannabis sales and help a struggling industry.
Cannabis rescheduling: potential distant impacts on healthcare providers
Kiliaen Strong of Dilworth Paxson LLP discusses the likely limited practical impact of potential rescheduling of cannabis without further developments by federal agencies, states or Congress.
Smaller Denver Cannabis Growers Closing, Freeing Up Warehouses
In March, Vireo closed a north Denver grow owned by PharmaCann Inc., which it acquired last year, according to the Denver Business Journal. The closure of the facility at 5131 Franklin St. will cut …
Four social equity cannabis businesses sue to block Massachusetts ballot question that would ban recreational pot sales
Four cannabis business owners allege the ballot question would unconstitutionally end state programs that help to fund and support enterprises like theirs.
A changing cannabis industry brings mixed feelings for operators of color
When Massachusetts residents voted to legalize recreational cannabis in 2016, many saw the shift as an opportunity for increased equity and economic opportunity in communities of color.
Michigan marijuana industry files another lawsuit to stop 24% wholesale tax
The initial lawsuit from the Michigan Cannabis Industry Association (MiCIA) filed last year is heading to trial in September, but late last week, the industry filed a new lawsuit against the Michigan …
Recent Comments